Search Tag: Safety
2014 25 Aug
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) is currently reviewing the safety of alteplase, a clot-busting drug. The drug is to be reviewed for the treatment of strokes. The regulatory agency believes that the benefits of alteplase outweigh its risks but because there is a chance that some previous assessments may have been flawed,...Read more
2013 22 May
Philips, the Radboud University Nijmegen Medical Centre (Nijmegen, the Netherlands) and Main-Taunus Cardiac Center (Bad Soden, Germany) announced the results of a clinical study that demonstrate that the safety for patients and clinicians can be significantly enhanced during cardiac interventions. Using Philips’ recently introduced AlluraClarity...Read more